Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy.

Conference Paper

OBJECTIVE: The objective was to explore psychosocial experiences of closed loop technology for adults, children, and adolescents with type 1 diabetes and their parents taking part in two multicenter, free-living, randomized crossover home studies. METHODS: Participants using insulin pump therapy were randomized to either 12 weeks of automated closed-loop glucose control, then 12 weeks of sensor augmented insulin pump therapy (open loop), or vice versa. Closed loop was used for 24 hours by adults and overnight only by children and adolescents. Participants completed the Diabetes Technology Questionnaire (DTQ) periodically and shared their views in semistructured interviews. This analysis characterizes the impact of the technology, positive and negative aspects of living with the device, alongside participants' expectations, hopes, and anxieties. RESULTS: Participants were 32 adults, age 38.6 ± 9.6 years, 55% male, and 26 children, mean age 12 years (range 6-18 years), 54% male. DTQ results indicated moderately favorable impact of, and satisfaction with, both open and closed loop interventions, but little evidence of a comparative advantage of either. Key positive themes included perceived improved blood glucose control, improved general well-being, particularly on waking, improved sleep, reduced burden of diabetes, and visibility of data. Key negative themes included having to carry around the equipment and dislike of the pump and second cannula (ie, sensor) inserted. CONCLUSIONS: Overall, participants reported a positive experience of the closed loop technology. Results are consistent with previous research with size of equipment continuing to be a problem. Progress is being made in the usability of the closed-loop system.

Full Text

Duke Authors

Cited Authors

  • Barnard, KD; Wysocki, T; Ully, V; Mader, JK; Pieber, TR; Thabit, H; Tauschmann, M; Leelarathna, L; Hartnell, S; Acerini, CL; Wilinska, ME; Dellweg, S; Benesch, C; Arnolds, S; Holzer, M; Kojzar, H; Campbell, F; Yong, J; Pichierri, J; Hindmarsh, P; Heinemann, L; Evans, ML; Hovorka, R

Published Date

  • November 2017

Published In

Volume / Issue

  • 11 / 6

Start / End Page

  • 1080 - 1088

PubMed ID

  • 28367636

Pubmed Central ID

  • PMC5951034

Electronic International Standard Serial Number (EISSN)

  • 1932-2968

Digital Object Identifier (DOI)

  • 10.1177/1932296817702656

Conference Location

  • United States